COMPASS Pathways Management
Management criteria checks 4/4
COMPASS Pathways' CEO is Kabir Nath, appointed in Aug 2022, has a tenure of 1.75 years. total yearly compensation is $2.82M, comprised of 21% salary and 79% bonuses, including company stock and options. directly owns 0.038% of the company’s shares, worth $222.33K. The average tenure of the management team and the board of directors is 2.3 years and 3.9 years respectively.
Key information
Kabir Nath
Chief executive officer
US$2.8m
Total compensation
| CEO salary percentage | 21.0% |
| CEO tenure | 1.8yrs |
| CEO ownership | 0.04% |
| Management average tenure | 2.3yrs |
| Board average tenure | 3.9yrs |
Recent management updates
Recent updates
COMPASS Pathways: Will MDMA-Assisted Therapy Pave The Way Or Slam The Door Shut?
Apr 25Compass Pathways: Psilocybin Developer A Potentially Intriguing, Contrarian Play
Feb 08Companies Like COMPASS Pathways (NASDAQ:CMPS) Are In A Position To Invest In Growth
Dec 06
Booker again pushes for easier access to psychedelics for terminally ill patients
Oct 19Here's Why We're Not Too Worried About COMPASS Pathways' (NASDAQ:CMPS) Cash Burn Situation
Aug 13COMPASS Pathways And The Trillion Dollar Opportunity
Aug 11COMPASS Pathways ADS Q2 2022 Earnings Preview
Aug 03COMPASS Pathways names new CEO
Jul 19Compass Pathways: Shares Look Cheap But Proving Psilocybin Case Won't Be Easy
Jun 30We're Hopeful That COMPASS Pathways (NASDAQ:CMPS) Will Use Its Cash Wisely
Apr 28Checking In On Compass Pathways
Mar 02We Think COMPASS Pathways (NASDAQ:CMPS) Can Afford To Drive Business Growth
Dec 29Compass Pathways: Psychedelics For Mental Health
Nov 23Compass Faces Tricky Road To Approval For Its Psychedelic Depressive Therapy
Sep 17COMPASS Pathways (NASDAQ:CMPS) Is In A Good Position To Deliver On Growth Plans
Sep 15Compass Pathways: Huge Growth Potential, But I'm Cautious
Jun 04COMPASS Pathways (NASDAQ:CMPS) Is In A Good Position To Deliver On Growth Plans
May 25COMPASS Pathways raises $144M capital via equity offering
Apr 30COMPASS Pathways launches public offering
Apr 27We're Not Very Worried About COMPASS Pathways' (NASDAQ:CMPS) Cash Burn Rate
Feb 08Psilocybin Will Change Mental Health, Compass Pathways Could Be At The Forefront
Jan 01Compass Pathways: Risky And Overvalued
Dec 18What Type Of Shareholders Make Up COMPASS Pathways plc's (NASDAQ:CMPS) Share Registry?
Dec 18COMPASS Pathways: Risky But Can Pay Back Generously
Dec 14Compass Pathways: An Overvalued Psychedelic Company With A Single Mediocre Drug
Nov 23COMPASS Pathways ADS reports Q3 results
Nov 12CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | US$3m | US$595k | -US$118m |
| Sep 30 2023 | n/a | n/a | -US$117m |
| Jun 30 2023 | n/a | n/a | -US$102m |
| Mar 31 2023 | n/a | n/a | -US$95m |
| Dec 31 2022 | US$8m | US$243k | -US$92m |
Compensation vs Market: Kabir's total compensation ($USD2.82M) is about average for companies of similar size in the US market ($USD2.41M).
Compensation vs Earnings: Kabir's compensation has been consistent with company performance over the past year.
CEO
Kabir Nath (59 yo)
1.8yrs
Tenure
US$2,824,758
Compensation
Mr. Kabir Kumar Nath M. A., M. B.A., is Chief Executive Officer and Director of COMPASS Pathways plc from August 1, 2022. He serves as President & CEO at Otsuka America Pharmaceutical, Inc. He served as Pr...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 1.8yrs | US$2.82m | 0.038% $ 222.3k | |
| General Counsel & Chief Legal Officer | 2.3yrs | US$1.32m | 0.0059% $ 34.6k | |
| Chief Medical Officer | 2.8yrs | US$1.20m | 0.0029% $ 17.1k | |
| CFO, Principal Financial Officer & Principal Accounting Officer | less than a year | no data | no data | |
| Chief Technology Officer | 2.3yrs | no data | no data | |
| Senior Vice President of Investor Relations | no data | no data | no data | |
| Chief Communications Officer | 1.6yrs | no data | no data | |
| Chief People Officer | no data | no data | no data | |
| Senior Advisor | 2.3yrs | no data | no data | |
| Chief Development Officer | 3.9yrs | no data | no data | |
| Advisor | no data | no data | no data | |
| Company Secretary | no data | no data | no data |
2.3yrs
Average Tenure
50yo
Average Age
Experienced Management: CMPS's management team is considered experienced (2.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 1.8yrs | US$2.82m | 0.038% $ 222.3k | |
| Member of Scientific Advisory Network | no data | no data | no data | |
| Independent Non Executive Director | 3.7yrs | US$209.48k | 0% $ 0 | |
| Independent Chairman & Lead Independent Director | 6yrs | US$173.10k | 0.025% $ 149.0k | |
| Independent Director | less than a year | US$363.71k | 0% $ 0 | |
| Independent Non Executive Director | 4.1yrs | US$166.91k | 0% $ 0 | |
| Independent Non-Executive Director | 3.2yrs | US$186.99k | 0% $ 0 | |
| Independent Non-Executive Director | 6yrs | US$199.82k | 0.13% $ 763.2k | |
| Independent Non-Executive Director | 6yrs | US$214.78k | 0.047% $ 276.7k | |
| Member of Scientific Advisory Network | no data | no data | no data | |
| Member of Scientific Advisory Network | no data | no data | no data | |
| Special Advisor of Patient Experience | no data | no data | no data |
3.9yrs
Average Tenure
66yo
Average Age
Experienced Board: CMPS's board of directors are considered experienced (3.9 years average tenure).